Characteristics and risk factors for COVID-19 diagnosis and adverse outcomes in Mexico: an analysis of 89,756 laboratory–confirmed COVID-19 cases
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Characteristics and risk factors for COVID-19 diagnosis and adverse outcomes in Mexico: an analysis of 89,756 laboratory–confirmed COVID-19 cases
Authors
Keywords
-
Journal
EUROPEAN RESPIRATORY JOURNAL
Volume -, Issue -, Pages 2002144
Publisher
European Respiratory Society (ERS)
Online
2020-07-31
DOI
10.1183/13993003.02144-2020
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The global epidemiology of hypertension
- (2020) Katherine T. Mills et al. Nature Reviews Nephrology
- Clinical Characteristics of Coronavirus Disease 2019 in China
- (2020) Wei-jie Guan et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- COVID-19, diabetes mellitus and ACE2: The conundrum
- (2020) Rimesh Pal et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- The pivotal link between ACE2 deficiency and SARS-CoV-2 infection
- (2020) Paolo Verdecchia et al. European Journal of Internal Medicine
- Current Smoking is Not Associated with COVID-19
- (2020) Marco Rossato et al. EUROPEAN RESPIRATORY JOURNAL
- COVID-19 and the nicotinic cholinergic system
- (2020) Konstantinos Farsalinos et al. EUROPEAN RESPIRATORY JOURNAL
- ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19
- (2020) Janice M. Leung et al. EUROPEAN RESPIRATORY JOURNAL
- Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis
- (2020) Wei-jie Guan et al. EUROPEAN RESPIRATORY JOURNAL
- Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option?
- (2020) Konstantinos Farsalinos et al. Internal and Emergency Medicine
- Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality
- (2020) Chi Zhang et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Managing COVID-19 in Low- and Middle-Income Countries
- (2020) Joost Hopman et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area
- (2020) Safiya Richardson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia
- (2020) Songping Cui et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
- (2020) Fei Zhou et al. LANCET
- Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19
- (2020) Harmony R. Reynolds et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neurologic Features in Severe SARS-CoV-2 Infection
- (2020) Julie Helms et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical Characteristics of Covid-19 in New York City
- (2020) Parag Goyal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study
- (2020) Annemarie B Docherty et al. BMJ-British Medical Journal
- COVID-19 Infection and Circulating ACE2 Levels: Protective Role in Women and Children
- (2020) Elena Ciaglia et al. Frontiers in Pediatrics
- Smoking Upregulates Angiotensin-Converting Enzyme-2 Receptor: A Potential Adhesion Site for Novel Coronavirus SARS-CoV-2 (Covid-19)
- (2020) Samuel James Brake et al. Journal of Clinical Medicine
- Estimates of the severity of coronavirus disease 2019: a model-based analysis
- (2020) Robert Verity et al. LANCET INFECTIOUS DISEASES
- Ending diabetes in Mexico
- (2019) Mathieu Levaillant et al. LANCET
- Glycemic Control and Risk of Infections Among People With Type 1 or Type 2 Diabetes in a Large Primary Care Cohort Study
- (2018) Julia A. Critchley et al. DIABETES CARE
- Obesity in Mexico: prevalence, comorbidities, associations with patient outcomes, and treatment experiences
- (2017) Marco D DiBonaventura et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Determinants of Underdiagnosis of COPD in National and International Surveys
- (2015) Bernd Lamprecht et al. CHEST
- Burden of type 2 diabetes in Mexico: past, current and future prevalence and incidence rates
- (2015) Rafael Meza et al. PREVENTIVE MEDICINE
- Inflammation and Cardiovascular Disease: From Pathogenesis to Therapeutic Target
- (2014) Enrica Golia et al. Current Atherosclerosis Reports
- Inflammation and Hypertension: New Understandings and Potential Therapeutic Targets
- (2014) Carmen De Miguel et al. CURRENT HYPERTENSION REPORTS
- The prevalence of chronic diseases and major disease risk factors at different ages among 150 000 men and women living in Mexico City: cross-sectional analyses of a prospective study
- (2009) Pablo Kuri-Morales et al. BMC PUBLIC HEALTH
- Loss of Angiotensin-Converting Enzyme 2 Accelerates Maladaptive Left Ventricular Remodeling in Response to Myocardial Infarction
- (2009) Zamaneh Kassiri et al. Circulation-Heart Failure
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started